-
1
-
-
0028170934
-
Tepoxalin: A dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile
-
D. C. Argentieri, D. M. Ritchie, M. P. Ferro, T. Kirchner, M. P. Wachter, D. W. Anderson, M. E. Rosenthal, and R. J. Capetola. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile. J. Pharmacol. Exp. Ther. 271:1399-1408 (1994).
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.271
, pp. 1399-1408
-
-
Argentieri, D.C.1
Ritchie, D.M.2
Ferro, M.P.3
Kirchner, T.4
Wachter, M.P.5
Anderson, D.W.6
Rosenthal, M.E.7
Capetola, R.J.8
-
2
-
-
21244481715
-
Effect of dietary fat on oral bioavailability of tepoxalin in dogs
-
L. M. Homer, C. R. Clarke, and A. J. Weingarten. Effect of dietary fat on oral bioavailability of tepoxalin in dogs. J. Vet. Pharmacol. Ther. 28:287-291 (2005).
-
(2005)
J. Vet. Pharmacol. Ther.
, vol.28
, pp. 287-291
-
-
Homer, L.M.1
Clarke, C.R.2
Weingarten, A.J.3
-
3
-
-
9344250076
-
Pharmacokinetics and pharmacodynamics of tepoxalin after single oral dose administration to healthy volunteers
-
S. A. Waldman, C. Vitow, B. Osborne, L. Gillen, D. C. Argentieri, F. A. Wong, I. L. Smith, A. T. Chow, J. Misiti, and T. D. Bjornsson. Pharmacokinetics and pharmacodynamics of tepoxalin after single oral dose administration to healthy volunteers. Clin. Pharmacol. 36:462-468 (1996).
-
(1996)
Clin. Pharmacol.
, vol.36
, pp. 462-468
-
-
Waldman, S.A.1
Vitow, C.2
Osborne, B.3
Gillen, L.4
Argentieri, D.C.5
Wong, F.A.6
Smith, I.L.7
Chow, A.T.8
Misiti, J.9
Bjornsson, T.D.10
-
4
-
-
40149088975
-
Single and multiple-dose pharmacokinetics of tepoxalin and its active metabolite after oral administration to rabbits (Oryctolagus cuniculus)
-
C. G. Pollock, J. W. Carpenter, D. E. Koch, and R. P. Hunter. Single and multiple-dose pharmacokinetics of tepoxalin and its active metabolite after oral administration to rabbits (Oryctolagus cuniculus). J. Vet. Pharmacol. Ther. 31:171-174 (2008).
-
(2008)
J. Vet. Pharmacol. Ther.
, vol.31
, pp. 171-174
-
-
Pollock, C.G.1
Carpenter, J.W.2
Koch, D.E.3
Hunter, R.P.4
-
5
-
-
58449111816
-
Pharmacokinetics of tepoxalin and its active metabolite in broiler chickens
-
S. de Boever, E. Neirinckx, K. Baert, P. de Backer, and S. Croubels. Pharmacokinetics of tepoxalin and its active metabolite in broiler chickens. J. Vet. Pharmacol. Ther. 32:97-100 (2009).
-
(2009)
J. Vet. Pharmacol. Ther.
, vol.32
, pp. 97-100
-
-
De Boever, S.1
Neirinckx, E.2
Baert, K.3
De Backer, P.4
Croubels, S.5
-
6
-
-
0035089518
-
Guidance for robustness: Ruggedness tests in method validation
-
Y. Vander Heyden, A. Nijhuis, J. Smeyers-Verbeke, B. G. M Vandeginste, and D. L. Massart. Guidance for robustness: ruggedness tests in method validation. J. Pharm. Biomed. Anal. 24:723-753 (2001).
-
(2001)
J. Pharm. Biomed. Anal.
, vol.24
, pp. 723-753
-
-
Heyden, Y.V.1
Nijhuis, A.2
Smeyers-Verbeke, J.3
Vandeginste, B.G.M.4
Massart, D.L.5
-
7
-
-
0030025369
-
Characterization of tepoxalin and its related compounds by high-performance liquid chromatography/mass spectrometry
-
D. J. Burinsky, B. L. Armstrong, A. R. Oyler, and R. Dunphy. Characterization of tepoxalin and its related compounds by high-performance liquid chromatography/mass spectrometry. Pharm. Sci. 85:159-164 (1996).
-
(1996)
Pharm. Sci.
, vol.85
, pp. 159-164
-
-
Burinsky, D.J.1
Armstrong, B.L.2
Oyler, A.R.3
Dunphy, R.4
|